BCIQ Profiles

Company Profile Report
0517 Cellares ECP
BioCentury & Getty Images

Emerging Company Profile

Cellares: marrying automation and flexibility in cell therapy manufacturing

Cellares’ walk-away cell manufacturing platform could go all the way from preclinical development to marketed product

Cellares’ walk-away cell manufacturing platform could go all the way from preclinical development to marketed product.

May 12, 2021 | 10:46 PM GMT

With a combined $100 million in venture funding, Cellares

Read the full 634 word article

How to gain access

Continue reading with a
two-week free trial.